Drug Type Small molecule drug |
Synonyms- |
Target |
Action modulators |
Mechanism ROS1 modulators(Proto-oncogene tyrosine-protein kinase ROS modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
dry age-related macular degeneration | Preclinical | South Korea | 01 Jun 2025 |